Works by Cselényi, Zsolt

Results: 26

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 880, doi. 10.2967/jnumed.112.114785

By:

Rowe, Christopher C.;
Pejoska, Svetlana;
Mulligan, Rachel S.;
Jones, Gareth;
Chan, J. Gordon;
Svensson, Samuel;
Cselényi, Zsolt;
Masters, Colin L.;
Villemagne, Victor L.

Publication type:

Article

Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand.

Published in:

Journal of Nuclear Medicine, 2012, v. 53, n. 3, p. 415, doi. 10.2967/jnumed.111.094029

By:

Cselényi, Zsolt;
Jönhagen, Maria Eriksdotter;
Forsberg, Anton;
Halldin, Christer;
Julin, Per;
Schou, Magnus;
Johnstrom, Peter;
Varnas, Katarina;
Svensson, Samuel;
Farde, Lars

Publication type:

Article

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy.

Published in:

Movement Disorders, 2022, v. 37, n. 8, p. 1776, doi. 10.1002/mds.29078

By:

Rinne, Juha O.;
Jucaite, Aurelija;
Cselényi, Zsolt;
Farde, Lars

Publication type:

Article

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis.

Published in:

Movement Disorders, 2022, v. 37, n. 1, p. 119, doi. 10.1002/mds.28814

By:

Jucaite, Aurelija;
Cselényi, Zsolt;
Kreisl, William C.;
Rabiner, Eugenii A.;
Varrone, Andrea;
Carson, Richard E.;
Rinne, Juha O.;
Savage, Alicia;
Schou, Magnus;
Johnström, Peter;
Svenningsson, Per;
Rascol, Olivier;
Meissner, Wassilios G.;
Barone, Paolo;
Seppi, Klaus;
Kaufmann, Horacio;
Wenning, Gregor K.;
Poewe, Werner;
Farde, Lars

Publication type:

Article

Nigrostriatal dopamine transporter availability in early Parkinson's disease.

Published in:

2018

By:

Fazio, Patrik;
Svenningsson, Per;
Cselényi, Zsolt;
Halldin, Christer;
Farde, Lars;
Varrone, Andrea

Publication type:

journal article

Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [ 11 C]AZD2423.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 135, doi. 10.3390/ph18020135

By:

Dahl, Kenneth;
Johnström, Peter;
Tóth, Miklós;
Bolin, Martin;
Varnäs, Katarina;
Nakao, Ryuji;
Takano, Akihiro;
Khani Meynaq, Yasir;
Bayrakdarian, Malken;
Cselényi, Zsolt;
Halldin, Christer;
Farde, Lars;
Schou, Magnus

Publication type:

Article

Radiosynthesis of the candidate β-amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.

Published in:

Synapse, 2010, v. 64, n. 10, p. 733, doi. 10.1002/syn.20782

By:

Andersson, Jan D.;
Varnäs, Katarina;
Cselényi, Zsolt;
Gulyás, Balázs;
Wensbo, David;
Finnema, Sjoerd J.;
Swahn, Britt-Marie;
Svensson, Samuel;
Nyberg, Svante;
Farde, Lars;
Halldin, Christer

Publication type:

Article

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography.

Published in:

Journal of Cerebral Blood Flow & Metabolism, 2022, v. 42, n. 4, p. 630, doi. 10.1177/0271678X211049185

By:

Veldman, Emma R;
Varrone, Andrea;
Varnäs, Katarina;
Svedberg, Marie M;
Cselényi, Zsolt;
Tiger, Mikael;
Gulyás, Balázs;
Halldin, Christer;
Lundberg, Johan

Publication type:

Article

Simplified quantification of [ 18 F]FE-PE2I PET in Parkinson's disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.

Published in:

Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 6, p. 1291, doi. 10.1177/0271678X20958755

By:

Brumberg, Joachim;
Kerstens, Vera;
Cselényi, Zsolt;
Svenningsson, Per;
Sundgren, Mathias;
Fazio, Patrik;
Varrone, Andrea

Publication type:

Article

A PET study in healthy subjects of brain exposure of 11 C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer.

Published in:

Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 4, p. 799, doi. 10.1177/0271678X19843776

By:

Varrone, Andrea;
Varnäs, Katarina;
Jucaite, Aurelija;
Cselényi, Zsolt;
Johnström, Peter;
Schou, Magnus;
Vazquez-Romero, Ana;
Moein, Mohammad M;
Halldin, Christer;
Brown, Andrew P;
Vishwanathan, Karthick;
Farde, Lars

Publication type:

Article

Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.

Published in:

Journal of Cerebral Blood Flow & Metabolism, 2015, v. 35, n. 9, p. 1485, doi. 10.1038/jcbfm.2015.66

By:

Cselényi, Zsolt;
Farde, Lars

Publication type:

Article

PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 2, p. 367, doi. 10.1007/s00259-018-4161-6

By:

Varnäs, Katarina;
Halldin, Christer;
Varrone, Andrea;
Cselényi, Zsolt;
Jucaite, Aurelija;
Farde, Lars;
Svenningsson, Per

Publication type:

Article

Low background and high contrast PET imaging of amyloid-β with [C]AZD2995 and [C]AZD2184 in Alzheimer's disease patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 4, p. 580, doi. 10.1007/s00259-012-2322-6

By:

Forsberg, Anton;
Juréus, Anders;
Cselényi, Zsolt;
Eriksdotter, Maria;
Freund-Levi, Yvonne;
Jeppsson, Fredrik;
Swahn, Britt-Marie;
Sandell, Johan;
Julin, Per;
Schou, Magnus;
Andersson, Jan;
Johnström, Peter;
Varnäs, Katarina;
Halldin, Christer;
Farde, Lars;
Svensson, Samuel

Publication type:

Article

Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 2, p. 228, doi. 10.1007/s00259-012-2260-3

By:

Schain, Martin;
Tóth, Miklós;
Cselényi, Zsolt;
Arakawa, Ryosuke;
Halldin, Christer;
Farde, Lars;
Varrone, Andrea

Publication type:

Article

Brain exposure of the ATM inhibitor AZD1390 in humans—a positron emission tomography study.

Published in:

Neuro-Oncology, 2021, v. 23, n. 4, p. 687, doi. 10.1093/neuonc/noaa238

By:

Jucaite, Aurelija;
Stenkrona, Per;
Cselényi, Zsolt;
Vita, Serena De;
Buil-Bruna, Nuria;
Varnäs, Katarina;
Savage, Alicia;
Varrone, Andrea;
Johnström, Peter;
Schou, Magnus;
Davison, Chris;
Sykes, Andy;
Reddy, Venkatesh Pilla;
Hoch, Matthias;
Vazquez-Romero, Ana;
Moein, Mohammad Mahdi;
Halldin, Christer;
Merchant, Melinda S;
Pass, Martin;
Farde, Lars

Publication type:

Article

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 11, p. 1859, doi. 10.1007/s00259-009-1182-1

By:

Nyberg, Svante;
Jönhagen, Maria;
Cselényi, Zsolt;
Halldin, Christer;
Julin, Per;
Olsson, Hans;
Freund-Levi, Yvonne;
Andersson, Jan;
Varnäs, Katarina;
Svensson, Samuel;
Farde, Lars

Publication type:

Article

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 8, p. 1031

By:

Gulyás, Balázs;
Halldin, Christer;
Sóvágó, Judit;
Sandell, Johan;
Cselényi, Zsolt;
Vas, Ádám;
Kiss, Béla;
Kárpáti, Egon;
Farde, Lars

Publication type:

Article

GABA receptor occupancy by subtype selective GABA modulators: PET studies in humans.

Published in:

Psychopharmacology, 2017, v. 234, n. 4, p. 707, doi. 10.1007/s00213-016-4506-4

By:

Jucaite, Aurelija;
Cselényi, Zsolt;
Lappalainen, Jaakko;
McCarthy, Dennis;
Lee, Chi-Ming;
Nyberg, Svante;
Varnäs, Katarina;
Stenkrona, Per;
Halldin, Christer;
Cross, Alan;
Farde, Lars

Publication type:

Article

[11C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome.

Published in:

Synapse, 2023, v. 77, n. 4, p. 1, doi. 10.1002/syn.22269

By:

Cselényi, Zsolt;
Wallin, Johan;
Tjerkoski, Jonathan;
Bloth, Björn;
Svensson, Samuel;
Nennesmo, Inger;
Sunnemark, Dan;
Jelic, Vesna;
Farde, Lars;
Svenningsson, Per

Publication type:

Article

Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study.

Published in:

Synapse, 2022, v. 76, n. 7/8, p. 1, doi. 10.1002/syn.22235

By:

Mattsson, Patrik;
Cselényi, Zsolt;
Andrée, Bengt;
Borg, Jacqueline;
Nag, Sangram;
Halldin, Christer;
Farde, Lars

Publication type:

Article

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.

Published in:

International Journal of Neuropsychopharmacology, 2013, v. 16, n. 10, p. 2235, doi. 10.1017/S1461145713000680

By:

Nyberg, Svante;
Jucaite, Aurelija;
Takano, Akihiro;
Kågedal, Matts;
Cselényi, Zsolt;
Halldin, Christer;
Farde, Lars

Publication type:

Article

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study.

Published in:

CTS: Clinical & Translational Science, 2023, v. 16, n. 6, p. 955, doi. 10.1111/cts.13500

By:

Ekman, Simon;
Cselényi, Zsolt;
Varrone, Andrea;
Jucaite, Aurelija;
Martin, Heather;
Schou, Magnus;
Johnström, Peter;
Laus, Gianluca;
Lewensohn, Rolf;
Brown, Andrew P.;
van der Aart, Jasper;
Vishwanathan, Karthick;
Farde, Lars

Publication type:

Article

Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects.

Published in:

EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00634-0

By:

Cselényi, Zsolt;
Jucaite, Aurelija;
Kristensson, Cecilia;
Stenkrona, Per;
Ewing, Pär;
Varrone, Andrea;
Johnström, Peter;
Schou, Magnus;
Vazquez-Romero, Ana;
Moein, Mohammad Mahdi;
Bolin, Martin;
Siikanen, Jonathan;
Grybäck, Pär;
Larsson, Bengt;
Halldin, Christer;
Grime, Ken;
Eriksson, Ulf G.;
Farde, Lars

Publication type:

Article

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Published in:

2015

By:

Jucaite, Aurelija;
Svenningsson, Per;
Rinne, Juha O.;
Cselényi, Zsolt;
Varnäs, Katarina;
Johnström, Peter;
Amini, Nahid;
Kirjavainen, Anna;
Helin, Semi;
Minkwitz, Margaret;
Kugler, Alan R.;
Posener, Joel A.;
Budd, Samantha;
Halldin, Christer;
Varrone, Andrea;
Farde, Lars

Publication type:

journal article

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Published in:

EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0455-8

By:

Plavén-Sigray, Pontus;
Matheson, Granville James;
Cselényi, Zsolt;
Jucaite, Aurelija;
Farde, Lars;
Cervenka, Simon

Publication type:

Article

Dose-dependent binding of AZD3783 to brain 5-HT receptors in non-human primates and human subjects: a positron emission tomography study with [C]AZ10419369.

Published in:

Psychopharmacology, 2011, v. 213, n. 2/3, p. 533, doi. 10.1007/s00213-011-2165-z

By:

Varnäs, Katarina;
Nyberg, Svante;
Karlsson, Per;
Pierson, M.;
Kågedal, Matts;
Cselényi, Zsolt;
McCarthy, Dennis;
Xiao, Alan;
Zhang, Minli;
Halldin, Christer;
Farde, Lars

Publication type:

Article

Works by Cselényi, Zsolt

Head-to-Head Comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia.

Clinical Validation of <sup>18</sup>F-AZD4694, an Amyloid-β-Specific PET Radioligand.

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy.

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [<sup>11</sup>C]PBR28 and Machine Learning Analysis.

Nigrostriatal dopamine transporter availability in early Parkinson's disease.

Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [ 11 C]AZD2423.

Radiosynthesis of the candidate β-amyloid radioligand [<sup>11</sup>C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography.

Simplified quantification of [ 18 F]FE-PE2I PET in Parkinson's disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.

A PET study in healthy subjects of brain exposure of 11 C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer.

Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.

PET imaging of [<sup>11</sup>C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding.

Low background and high contrast PET imaging of amyloid-β with [C]AZD2995 and [C]AZD2184 in Alzheimer's disease patients.

Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.

Brain exposure of the ATM inhibitor AZD1390 in humans—a positron emission tomography study.

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [<sup>11</sup>C]AZD2184.

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

GABA receptor occupancy by subtype selective GABA modulators: PET studies in humans.

[<sup>11</sup>C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome.

Decreased 5‐HT<sub>1A</sub> binding in mild Alzheimer's disease—A positron emission tomography study.

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study.

Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects.

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Test-retest reliability and convergent validity of (R)-[<sup>11</sup>C]PK11195 outcome measures without arterial input function.

Dose-dependent binding of AZD3783 to brain 5-HT receptors in non-human primates and human subjects: a positron emission tomography study with [C]AZ10419369.